NDC Code(s) : 67046-992-30, 67046-993-30
Packager : Contract Pharmacy Services-PA
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : CIII
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
BuprenorphineBuprenorphine Hydrochloride TABLET | ||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
BuprenorphineBuprenorphine Hydrochloride TABLET | ||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
NDC 0228-3156-03
Buprenorphine
Sublingual Tablets
2 mg
30 Tablets
Rx Only
![PRINCIPAL DISPLAY PANEL NDC 0228-3156-03 Buprenorphine Sublingual Tablets 2 mg 30 Tablets Rx Only](/xml/58ada269-01fb-536f-e053-2a91aa0ab5af/buprenorphine-sublingual-tablets-5.jpg)
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
NDC 0228-3153-03
Buprenorphine
Sublingual Tablets
8 mg
30 Tablets
Rx Only
![PRINCIPAL DISPLAY PANEL NDC 0228-3153-03 Buprenorphine Sublingual Tablets 8 mg 30 Tablets Rx Only](/xml/58ada269-01fb-536f-e053-2a91aa0ab5af/buprenorphine-sublingual-tablets-6.jpg)